Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H22O2 |
Molecular Weight | 270.3661 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]3([H])C4=C(CC[C@@]23[H])C=C(O)C=C4
InChI
InChIKey=DNXHEGUUPJUMQT-CBZIJGRNSA-N
InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1
Molecular Formula | C18H22O2 |
Molecular Weight | 270.3661 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:02:46 UTC 2023
by
admin
on
Sat Dec 16 16:02:46 UTC 2023
|
Record UNII |
2DI9HA706A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
25403-7
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
2258-2
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LIVERTOX |
376
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
13739-8
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
WHO-ATC |
G03CA07
Created by
admin on Sat Dec 16 16:02:47 UTC 2023 , Edited by admin on Sat Dec 16 16:02:47 UTC 2023
|
||
|
LOINC |
22663-9
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
34297-2
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
34299-8
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
31177-9
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
CFR |
21 CFR 862.1430
Created by
admin on Sat Dec 16 16:02:47 UTC 2023 , Edited by admin on Sat Dec 16 16:02:47 UTC 2023
|
||
|
LOINC |
27998-4
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
2257-4
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
6776-9
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
35208-8
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
2261-6
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
WHO-ATC |
G03CC04
Created by
admin on Sat Dec 16 16:02:47 UTC 2023 , Edited by admin on Sat Dec 16 16:02:47 UTC 2023
|
||
|
LOINC |
14160-6
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
34298-0
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
2260-8
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
2262-4
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
LOINC |
2259-0
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
WHO-VATC |
QG03CA07
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
||
|
CFR |
21 CFR 862.1280
Created by
admin on Sat Dec 16 16:02:47 UTC 2023 , Edited by admin on Sat Dec 16 16:02:47 UTC 2023
|
||
|
WHO-VATC |
QG03CC04
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
ESTRONE
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
53-16-7
Created by
admin on Sat Dec 16 16:02:47 UTC 2023 , Edited by admin on Sat Dec 16 16:02:47 UTC 2023
|
PRIMARY | |||
|
2DI9HA706A
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
CHEMBL1405
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
2DI9HA706A
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
C484
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
SUB07251MIG
Created by
admin on Sat Dec 16 16:02:47 UTC 2023 , Edited by admin on Sat Dec 16 16:02:47 UTC 2023
|
PRIMARY | |||
|
9699
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
3188
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
100000082364
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
200-164-5
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
2818
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
Estrone (medication)
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
3324
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
D004970
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
5870
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
407
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
17263
Created by
admin on Sat Dec 16 16:02:47 UTC 2023 , Edited by admin on Sat Dec 16 16:02:47 UTC 2023
|
PRIMARY | |||
|
4103
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | RxNorm | ||
|
m5033
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | Merck Index | ||
|
DB00655
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
1255001
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY | |||
|
DTXSID4022367
Created by
admin on Sat Dec 16 16:02:48 UTC 2023 , Edited by admin on Sat Dec 16 16:02:48 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
IN-VITRO
Scientific Literature
|
||
|
PARENT -> METABOLITE |
E2 is then extensively metabolized to estrone (E1) (15%), estrone sulfate (E1S) (65%), and other compounds.
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
IN-VITRO
Scientific Literature
|
||
|
METABOLITE -> PARENT |
IN-VIVO
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (TLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |